PRACTICAL APPROACHES TO THE OPTIMIZATION OF MICROBIAL ECOLOGY OF THE DIGESTIVE TRACT IN CHILDREN


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

This review article provides information on clinical studies on the evaluation of normal intestinal microbiota, its formation and positive functions. Particular attention is focused on the controlling role of the mucin layer. The issues of the ability of probiotics to exert a protective effect on the intestinal barrier, antagonistic effect on conditionally pathogenic microorganisms and stimulating effect on immunity are discussed. The master seed species and strains that are part of the probiotic preparations, the most studied from the point of view of evidence-based medicine are considered.

Толық мәтін

Рұқсат жабық

Авторлар туралы

N. Ursova

SBHCI MR «Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky»

Email: ursovan@mail.iu
MD, Prof., Head of the Pediatric Unit, Head of the Department of Pediatrics Moscow

Әдебиет тізімі

  1. Parfrey L.W., Knight R. Spatial and temporal variability of the human microbiota. Clin. Microbiol. Infect. 2012;18(4):8-11.
  2. Matamoros S., Gras-Leguen C., Le Vacon F., Potel G., de La Cochetiere M.F. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol. 2013; 21:167-73.
  3. Oozeer R., Rescigno M., Ross R.P, Knol J., Blant M., Khlebnikov A., Dore J. Gut health: predictive biomarkers for preventive medicine and development of functional foods. Br. J. Nutr. 2010;103:1539-44.
  4. Voreades N., Kozil A., Weir T.L. Diet and the development of the human intestinal microbiome. Front. Microbiol. 2014;5:494.
  5. Lee K.N., Lee O.Y. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J. Gastroenterol. 2014;20:8886-97.
  6. Manyaka P., Khafipour E., Ghia J.E. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front. in Pediatrics. 2014; 2:109-24.
  7. Miller M.B., Bassler B.I. Quorum sensing in bacteria. Ann. Rev. Microbiol. 2001; 55:165-99.
  8. Dethlefsen L., Eckburg P.B., Bik E.M., Relman D.A. Assembly of the human intestinal microbiota. Trends Ecol. Evol. 2006;21: 517-23.
  9. Shapiro H., Thaiss C.A., Levy M., Elinav E. The cross talk between microbiota and the immune system: metabolites take center stage. Curr. Opin. Immunol. 2014;30:54-62.
  10. Gerritsen J., Smidt H., Rijkers G.T., De Vos W.M. Intestinal microbiota in human health and disease: the impact of probiotics. Genes. Nutr. 2011;6:209-40.
  11. Wopereis H., Oozeer R., Knipping K., Beizer C., Knol J. The first thousand days-intestinal microbiology of early life: establishing a symbiosis. Pediatr. Allergy Immunol. 2014;25:428-38.
  12. Puertollano E., Kolida S., Yaqoob P. Biolodical significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr. Opin. Clin. Nutr. Metab. Care. 2014;17(2):139-44.
  13. Scholtens P., Oozeer R., Martin R., Amor K.B., Knol J. The early settlers: intestinal microbiology in early life. Ann. Rev. Food Sci. Technol. 2012;3:425-27.
  14. Martin R., Nauta A.J., Amor K.B., Knippels L.M.J., Knol J., Garssen J. Early life: gut microbiota and immune development in infancy. Benef. Microbes. 2010;1:367-82.
  15. Deplancke B., Gaskins H.R. Microbial modulation of innate defense: goblet cell and the intestinal mucus layer. Am. J. Clin. Nutr. 2001;73:1131-41.
  16. McDermott A., Huffnagle B. The microbiome and regulation of mucosal immunity. Immunology. 2013;142:24-31.
  17. Purchiaroni F., Tortora A., Gabrielli M., Bertucci F., Gigante G., Ianiro G., Ojetti V., Scarpellini E., Gasbarrini A. The role of intestinal microbiota and the immune system. Eur. Rev. Med. Pharmacol Sci. 2013;17:323-33.
  18. Tannock G.W. Molecular assessment of intestinal microflora. Am. J. Clin. Nutr. 2001;73:410-14.
  19. Adlerberth I., Cerqueti M., Poilane I., Wold A., Collignon A. Mechanisms of colonization and colonization resistance of the digestive tract. Part 1. Bacteria/Host interactions. Microbial. Ecol. Health Dis. 200;(Supp. l2):223-39.
  20. Costerton J.W. Microbial biofilms. Ann. Rev. Microbiol. 1995;49:711-45.
  21. Flemming H.C., Neu T.R., Wozniak D.J. The EPS matrix: the "house of biofilm cells". J. Bacteriol. 2007;189(22):7945-47.
  22. Hall-Stoodley L., Stoodley P. Evolving concepts in biofilm infections. Cell. Microbiol. 2009;11(7):1034-43.
  23. Liu Y., Li J. Role of Pseudomonas aeruginosa biofilm in the initial adhesion, growth and detachment of Escherichia coli in porous media. Environ. Scien. Technol. 2008;42(2):443-49.
  24. Kim Y.S., Ho S.B. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr. Gastroenterol. Rep. 2010;12(5):319-30.
  25. Johansson M.E., Phillipson M., Petersson J., Velcich A., Holm L., Hansson G.C. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA. 2008;105(39):15064-69.
  26. Ouwerkerk J.P., de Vos W.M., Belzer C. Clycobiome: bacteria and mucus at the epithelial interface. Best Pract. Res. Clin. Gastroenterol. 2013;27(1):25-38.
  27. Chen S.J., Liu X.W., Liu J.P., Yang X.Y., Lu F.G. Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World J. Gastroenterol. 2014;20(28):9468-75.
  28. Staib L., Fuchs T.M. From food to cell: nutrient exploitation strategies of enteropathogens. Microbiology. 2014;160(6):1020-39.
  29. Shen L. Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann. N. Y. Acad. Sci. 2012;1258:9-18.
  30. Dethlefsen L., Eckburg P.B., Bik E.M., Relman D.A. Assembly of the human intestinal microbiota. Trends Ecol. Evol. 2006; 21:517-23.
  31. Cani PD. Metabolism in 2013: the gut microbiota manages host metabolism. Nat. Rev. Endocrinnol. 2014;10(2):74-6.
  32. Abreu M.T. Toll-like receptor signaling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 2010;10(2):131-44.
  33. Kamada N., Chen G.Y., Inohara N., Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 2013;14(7):685-90.
  34. Bischoff S. Gut health: a new objective in medicine? BMC. Med. 2014;9:24.
  35. Шендеров Б.А. Медицинская микробная экология и функциональное питание. Т. 3: Пробиотики и функциональное питание. М., 2001. 286 с.
  36. Guinane C.M., Cotter P.D. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap. Adv. Gastroenterol. 2013;6:295-308.
  37. World Gastroenterology Organization practice guideline: Probiotics and prebiotics. Arab. J. Gastroenterology. 2009;10(1):33-42.
  38. Binns N. Internationsl life sciences institute (ISLI) Europe: concise monograph series. Probiotics, prebiotics and the gut microbiota. Available at: http://www.hablemosclaro.org/ Repositorio/biblioteca/b_332_Prebiotics-Probiotics_ILSI_(ing).pdf.
  39. Hill C., Guamer F., Reid G. The International scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014; 11:505-14.
  40. Timmerman H.M., Koning C.J.M., Mulder L., Rombouts F.M., Beynen A.C. Monostrain, multistrain and multispecies probiotics. A comparison of functionality and efficacy. Int. J. Food Microbiol. 2004;96:219-33.
  41. Collignon A., Sandre C., Barc M.C. Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment. Gastroenterol. Clin. Biol. 2010;34(1):71-8.
  42. Tannock G.W. Molecular assessment of intestinal microflora. Am. J. Clin. Nutr. 2001;73:410-14.
  43. Resta-Lenert S., Barrett K. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli. Gut. 2003;52:988-97.
  44. Putaala H., Salusjarvi T. Effect of four probiotic strains and Echerichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res. Microbiol. 2008;doi: 10.1016/j.resmic.2008.08.002.
  45. Alakomi H.L., Skytta E., Saarela M., Mattila-Sandholm T., Latva-Kala K., Helander L.M. Lactic acid permebilizes gram-negative bacteria by disrupting the outer membrane. Applied. Environ. Microbiol. 2000; 66:2001-5.
  46. Pan X., Chen F., Wu T. The acid, bile tolerance and antimicrobial property of Lactobacillus acidophilus NIT. Food Control 2008;doi: 10.1016/j.foodcont.2008.08.019.
  47. Salminen S., Salminen E. Lactulose lactic acid bacteria intestinal microecology and mucosal protection. Scand. J. Gastroenterol. 1997;222:45-8.
  48. Lanning D.K., Rhee K.J., Knight K.L. Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol. 2005; 26(8):419-25.
  49. Cotter P.D., Hill C., Ross R.P Developing innate immunity for food. Nat. Rev. Microbiol. 2005;3:777-88.
  50. Strompfova V., Laukova A. In vitro study on bacteriocin production of Enterococci associated with chickens. Anaerobe. 2007;13:228-37.
  51. Chavez A.M., Menconi M.J., Hodin R.A., Fink M.P. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit. Care Med. 1999;27:2246-51.
  52. Sobko T., Reinders C.L., Jansson E.A., Norin E., Midtvedt T., Lundberg J.O. Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric. Oxide. 2005;13:163-69. 53. Lundberg J.O., Weitzberg E., Cole J.A., Jansson E.A., Norin E. Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2004; 2:593-602.
  53. Schoeder B., Winckler C., Failing K., Breves G. Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum. Dig. Dis. Sci. 2004;49(7-8):1311-17.
  54. Lu L., Walker A. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am. J. Clin. Nutr. 2001; 73:1124-30.
  55. Shida K., Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends. Immunol. 2008;29:565-73.
  56. Lebeer S., Vanderleydes G., De Keersmaecker S.C. Genes and molecules of lactobacillus supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008;72:728-64.
  57. Perdigon G., Fuller R., Raya R. Lactis acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2001; 2(1):27-42.
  58. Barreto-Bergter E., Figueiredo R.T. Fungal glycans and the innate immune recognition. Front. Cell Infect. Microbiol. 2014;4:145.
  59. Samuelsen A.B., Schrezenmeir J., Knutsen S.H. Effects of orally administered yeast-derived β-glucans: a review. Mol. Nutr. Food Res. 2014;58(1):183-93.
  60. Лиходед В.Г., Бондаренко В.М. Антиэндотоксиновый иммунитет в регуляции численности микрофлоры кишечника. Медицина. М., 2007. 216 с.
  61. Gill H.S. Probiotics to enhance anti-infective defenses in gastrointestinal tract. Best. Pract. Res. Clin. Gastroenterol. 2003;17:755- 73.
  62. Applegate J.A., Christa L.F.W., Ramya A., Robert E.B. Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children. BMC. Public. Health. 2013;13(3):S16.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>